Medical Condition News

RSS

Research focuses on JQ1 molecule that tricks NUT midline carcinoma cancer cells

NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.

29 Oct 2011

Cancer symposium at Georgetown focuses on 'Linking Policy to the Patient'

The Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center announces a three-part symposium, titled "Fighting a Smarter War Against Cancer: Linking Policy to the Patient," to be held Thursday, December 1 through Saturday, Dec. 3, 2011 on the campuses of Georgetown University and Georgetown University Law Center in Washington, D.C.

29 Oct 2011

Researcher's compound disables bacteria instead of killing them

After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?

29 Oct 2011

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

This study examined Medicare data on beneficiaries diagnosed with colorectal cancer between 1995 and 2005 who ranged from 67 to 85 years old. The authors found, "Medicare beneficiaries with colon cancer had better outcomes if they had more primary care utilization before diagnosis. Even within this universally insured population, 28% of Medicare beneficiaries with colon cancer had no or only 1 contact with primary care physicians in the 3 to 27 months before the diagnosis.

29 Oct 2011

Research breakthrough in lung regeneration

Scientists at A*STAR'S Genome Institute of Singapore (GIS) and Institute of Molecular Biology (IMB), have made a breakthrough discovery in the understanding of lung regeneration. Their research showed for the first time that distal airway stem cells (DASCs), a specific type of stem cells in the lungs, are involved in forming new alveoli to replace and repair damaged lung tissue, providing a firm foundation for understanding lung regeneration.

29 Oct 2011

Thanksgiving Day tips for people with food allergies

Thanksgiving is about family, food and travel. And for the millions of Americans with allergies or asthma, it's about navigating a minefield of triggers, from the pumpkin pie to the dusty guest bedroom. "A number of holiday-related triggers can make people sneeze, wheeze or, in the case of food allergies, have a more serious reaction," said allergist Dr. Myron Zitt, past president of the Allergy, Asthma and Immunology (ACAAI). "But by planning ahead, the day can go smoothly for people with allergies or asthma."

29 Oct 2011

More than 50,000 patients at high risk of SCA have been prescribed ZOLL's LifeVest

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest Wearable Defibrillator.

29 Oct 2011

Tips for people with allergies and asthma to enjoy holiday gatherings

Holiday gatherings are festive fun, but it's not easy to be the life of the party when you're sniffling, sneezing and wheezing. From the host's overpowering perfume to the nuts in the snack bowl, holiday parties can be a challenge for people with allergies and asthma.

29 Oct 2011

Study: Reduced secretion of beta-amyloid signals beginning of Alzheimer's

For decades the amyloid hypothesis has dominated the research field in Alzheimer's disease. The theory describes how an increase in secreted beta-amyloid peptides leads to the formation of plaques, toxic clusters of damaged proteins between cells, which eventually result in neurodegeneration. Scientists at Lund University, Sweden, have now presented a study that turns this premise on its head.

29 Oct 2011

Massachusetts court awards injunction preventing Watson from selling Amphastar's generic LOVENOX

Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Massachusetts has granted Momenta Pharmaceuticals, Inc. and Sandoz Inc.'s request for a preliminary injunction preventing Watson and Amphastar Pharmaceuticals, Inc. from marketing or selling Amphastar's Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis' LOVENOX.

29 Oct 2011

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

In our continued commitment to develop an artificial pancreas, Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) to conduct a pivotal in-home clinical trial protocol for the ASPIRE study of the MiniMed Paradigm System featuring Low Glucose Suspend (LGS) automation.

From Medtronic 29 Oct 2011

Thyroidectomy reduces snoring associated with obstructive sleep apnea

Obstructive sleep apnea, caused by narrowing or blockage of the airways when a person is asleep affects about 20% of the population. Typically a person with OSA will begin snoring loudly on falling asleep. If not treated, obstructive sleep apnea (OSA) can increase a person's risk of death. It is not clear whether an enlarged thyroid gland, known as a goiter, can worsen cause or worsen symptoms of OSA by compressing the airway.

29 Oct 2011

Third Annual Translational Cancer Medicine Symposium to be held on Dec. 2

The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. - 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.

29 Oct 2011

MEDA files marketing authorization application for Dymista in Europe

The marketing authorization application for Dymista (a novel formulation of azelastine hydrochloride and fluticasone propionate) has been filed in Europe. The application uses a decentralized procedure and the reference member state is Germany.

29 Oct 2011

Meriter to join Wisconsin Heart & Vascular Institute

Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.

29 Oct 2011

Preventive use of ACZ may reduce risk of severe high altitude illness

Measuring specific, exercise-related responses can help physicians determine who may be more at risk for severe high altitude illness (SHAI), according to a study conducted by researchers in France. The researchers also found that taking acetazolamide (ACZ), a drug frequently prescribed to prevent altitude illness, can reduce some of the risk factors associated with SHAI.

29 Oct 2011

The West Clinic to partner with Methodist for cancer care

Methodist Healthcare and The West Clinic have entered into a partnership, effective January 1, 2012, to transform cancer care in the Mid-South area. The West Clinic, the region's premier cancer practice and a nationally-recognized leader in cancer research, is joining forces with Methodist to create a comprehensive, fully integrated cancer service for the benefit of Mid-South residents.

29 Oct 2011

Specific metabolic disturbances precede children's progression to Type 1 diabetes

New potential avenues for early disease detection and prevention: A study led by Matej Orešič from VTT Technical Research Centre of Finland suggests that autoimmune diabetes is preceded by diminished gut microbial diversity of the Clostridium leptum subgroup, elevated plasma leptin and enhanced glucose-stimulated insulin secretion.

29 Oct 2011

LCA hails NCCN for lung cancer screening guidelines

Today Lung Cancer Alliance (LCA) hailed the leadership of the National Comprehensive Cancer Network (NCCN) for being the first professional society to recommend low-dose CT screening for high risk individuals and to develop comprehensive clinical practice guidelines on lung cancer screening.

29 Oct 2011

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

Eli Lilly and Company announced today that the European Commission has granted approval for the use of ALIMTA (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer

29 Oct 2011